ArticleJournal of personalized medicine2021

Downregulation of ATM and BRCA1 Predicts Poor Outcome in Head and Neck Cancer: Implications for ATM-Targeted Therapy.

Yu-Chu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.